Actively Recruiting
High-Resolution Magnetic Resonance Imaging Study of Intracranial Atherosclerotic Plaques in Ischemic Stroke Patients in China
Led by General Hospital of Shenyang Military Region · Updated on 2026-09-11
2110
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying intracranial atherosclerotic disease, a leading cause of ischemic stroke in Asia, particularly China. This prospective, multicenter cohort study aims to use high-resolution magnetic resonance imaging HRMRI to evaluate intracranial arterial plaques in patients with ischemic stroke. HRMRI technology allows detailed, non-invasive assessment of vascular wall and plaque composition, which is important for understanding stroke causes and guiding prevention strategies. Participants will undergo HRMRI to assess the characteristics of intracranial plaques, such as lipid-rich cores, fibrous cap thickness, hemorrhage, and calcification. This observational study collects clinical data and monitors patients without administering any experimental treatments. The study seeks to establish a large HRMRI database for intracranial artery plaques among Chinese patients with ischemic stroke. During the study, participants will be evaluated for stroke recurrence and cardiovascular events at 90, 180, and 360 days. Functional independence and the relationship between plaque characteristics and cerebral small vessel disease burden will also be measured. Stroke outcomes will be assessed using tools like the modified Rankin Scale. The study involves clinical assessments and imaging over a full year to monitor health status and stroke recurrence.
CONDITIONS
Brief Title
High-resolution Magnetic Resonance Imaging of Intracranial Atherosclerotic Plaques in Ischemic Stroke
Research Team
H
HuiSheng
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here